جاباپنتين تيڤع ٣٠٠ ملغ إسرائيل - العربية - Ministry of Health

جاباپنتين تيڤع ٣٠٠ ملغ

teva pharmaceutical indust.ltd - gabapentin 300 mg - capsules - gabapentin - - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy. - for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy (neuralgia).

ستيلنوكس ١٠ ملغ أقراص إسرائيل - العربية - Ministry of Health

ستيلنوكس ١٠ ملغ أقراص

sanofi - aventis israel ltd - zolpidem tartrate 10 mg - tablets - zolpidem - indications are limited to treatment of severe sleep disorders in the following cases: - occasional insomnia - transient insomnia.

ميرتازاپين تيڤع ۳٠ ملغ إسرائيل - العربية - Ministry of Health

ميرتازاپين تيڤع ۳٠ ملغ

teva pharmaceutical indust.ltd - mirtazapine 30 mg - tablets - mirtazapine - episode of major depression.

كسالاتان إسرائيل - العربية - Ministry of Health

كسالاتان

pfizer pharmaceuticals israel ltd - latanoprost 50 mcg/ml - eye drops - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.

تريتايس ٢٫٥ ملغ إسرائيل - العربية - Ministry of Health

تريتايس ٢٫٥ ملغ

sanofi - aventis israel ltd - ramipril 2.5 mg - tablets - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

كسالاكوم قطره للعينين إسرائيل - العربية - Ministry of Health

كسالاكوم قطره للعينين

pfizer pharmaceuticals israel ltd - latanoprost 50 mcg/ml; timolol as maleate 5 mg/ml - eye drops - other antiglaucoma preparations - reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.